|
|
|
|
|
by riskassessment
109 days ago
|
|
I don't understand this reasoning. Randomizing people to AI vs standard of care is expensive and risky. Checking whether the AI can pass hypothetical scenarios seems like a perfectly reasonable approach to researching the safety of these models before running a clinical trial. |
|